Browse > Article
http://dx.doi.org/10.5352/JLS.2008.18.2.241

Study on Anti-Helicobacter pylori Antibody of Sparated Antigen from H. pylori  

Park, Chang-Ho (Daegu Bio Industry Center)
Bae, Man-Jong (Department of Oriental Medicine Biofood Science, Daegu Haany University)
Publication Information
Journal of Life Science / v.18, no.2, 2008 , pp. 241-248 More about this Journal
Abstract
This study has been carried out to secretion antibodies for the purpose of preventing the infection of Helicobacter pylori and using them as a supplement for treatment. This experiments have been separated antigens from H. pylori and observed into antibody production and the agglutination of H. pylori for the separated antigens. As major antigenic proteins separated from H. pylori, the following could be verified: 12 kinds of band for whole cell (WC), seven kinds of band for outer membrane protein (OMP), three kinds of band for crude urease, and one kind of band for lipopolysaccharide (LPS). The IgG anti-H. pylori antibody of separated antigens showed $77.9{\pm}6.4{\mu}g/ml$ for we (L), $84.9{\pm}6.4{\mu}g/ml$ for OMP, and $123.8{\pm}2.9{\mu}g/ml$ for crude urease, at the same antigen concentration of $20{\mu}g/100ull$, which showed the most at the crude urease. And it turned out that the IgA antibodies were generated with $2.5{\pm}0.32{\mu}g/ml$ for WC (L), $2.0{\pm}0.43{\mu}g/ml$ for OMP, and $1.3{\pm}0.25{\mu}g/ml$ for crude urease, which demonstrated the most for WC (L) antigens. As a result of verifying the immunogenecity of antigenic protein through the Western blotting, major antigenic substances could be confirmed as follows: 10 kinds for WC, six kinds for OMP and three kinds for crude urease. The agglutination values on the H. pylori of the antibody were $2^5,\;2^5,\;2^6\;and\;2^7$ at the antigen serums of anti-WC (H), anti-WC (L), anti-OMP and anti-crude urease, respectively, which indicated the highest for the antigen serum of anti-crude urease. The urease activation-inhibiting absorbance of antigen serum created by each antigen was $0.14{\pm}0.01$ for WC (H), $0.16{\pm}0.01$ for WC (L), $0.18{\pm}0.03$ for OMP, and $0.18{\pm}0.04$ for urease, demonstrating a significant inhibiting effect, compared with $0.26{\pm}0.02$ of the control group.
Keywords
Helicobacter pylori; anti-H. pylori antibody; whole cell; outer membrane protein; lipopolysaccharide; urease;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hazell, S. L. and A. Lee. 1986. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet. 11, 15-17
2 Kim, B. J., B. H. Kang, T. Y. Kim, T. H. Kim, and K. W. Kim. 1997. Production and characterization of IgY specific to Helicobacter pylori. Kor. J. Appl. Microbiol. Biotechnol. 25, 612-616
3 Marshall, B. J. and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 323, 1311-1315   DOI   ScienceOn
4 Michetti, P., I. Corthesy-Theulaz, C. Davin, R. Haas, A. C. Vaney, M. Heitz, J. Bille, J. P. Kraehenbuhl, E. Saraga and A. L. Blum. 1994. Immunization of BALB/c mice against Helicobacter felis infection With Helicobacter pylori urease. Gastrol. 107, 1002-1011   DOI
5 Sabarth, N., R. Hurwitz, T. F. Meyer and D. Bumann. 2002. Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with protective efficacy. Infect Immun. 11, 6499-6503
6 Smythies, L. E., J. N. Miroslav, B. W. Ken, D. M. Casey and D. S. Phillip. 2005. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection. vaccine. 23, 901-909   DOI   ScienceOn
7 Hu, L. T. and H. L. Mobley. 1990. Purification and N-Terminal analysis of urease from Helicobacter pylori. Infect immun. 58, 992-998
8 Aebischer, T., A. Schmitt, A. K. Walduck and T. F. Meyer. 2005. Helicobacter pylori vaccine development: facing the challenge. Inter. J. Med. Microbiol. 295, 343-353   DOI   ScienceOn
9 Koivunen, M. E., M. Christophe, W. N. John, R. H. William and D. H. Bruce. 2003. Purification and characterization of a methylen urea-hydrolyzing enzyme from Rhixobium radiobacter (Agrobacterium tumefaciens). Soil Biol. Biochem. 35, 1433-1442   DOI   ScienceOn
10 Rahn, W., R. W. Redline and T. G. Blanchard. 2004. Molecular analysis of Helicobacter pylori-associated gastric inflammation in naive versus previously immunized mice. Vaccine 23, 807-818   DOI   ScienceOn
11 Newell, D. G., H. McBride and A. D. Pearson. 1984. The identification of outer membrane proteins and flagella of Cmpylobacter jejuni. J. Gene Microbiol. 130, 1201-1208
12 Sreevatsan, S., T. R. Ames, R. E. Werdin, H. S. Yoo and S. K. Maheswaran. 1996. Evaluation of three experimental subunit vaccines against pneumonic pasteurellosis in cattle. Vaccine 14, 147-154   DOI   ScienceOn
13 Fomsgaard, A., M. A. Freudenberg and C. Galanos. 1993. The modification of the silver stain method in sodium dodecyl sulfate polyacrylamide gels for detecting lipopolysaccharides. J. Kor. Soc. Microbiol. 28, 193-198
14 Roe, E. H., S. W. Nam, M. R. Yang, J. T. Kim and J. H. Shin. 2002. The promising effect of Egg Yolk antibody (Immunoglobulin Yolk) on the treatment of Helicobacter pylori- associated gastric diseases. Kor. J. Gastrol. 39, 260-268
15 Wyatt, J. I., B. J. Rathbone and R. V. Heatley. 1986. Local immune response to gastric Campylobacter in non-ulcer disease. J. Clin. Pathol. 39, 863-870   DOI
16 Britton, S, E., Papp-Szabo, J. Simala-Grant, L. Morrison, D. E. Taylor and M. A. Monteiro. 2005. A novel Helicobacterpylori cell-surface polysaccharide. Carbohydr. Res. 340, 1605-1611   DOI   ScienceOn
17 Hamstra, H. J., B. Kuipers, D. Schijf-Evers, H. G. Loggen and J. T. Poolman. 1995. The purification and protective capacity of Bordetella pertussis outer membrane protein. Vaccine 13, 747-752   DOI   ScienceOn
18 Jauho, E. S., U. Boas, C. Wiuff, K. Wredstrom, B. Pedersen, L. O. Andresen, P. M. Heegaard and M. H. Jakobsen. 2000. New technology for regiospecific covalent coupling of polysaccharide antigens in ELISA for serological detection. J. Immunol. Med. 242, 133-143   DOI   ScienceOn
19 Burr, D. H., D. Rollins, L. H. Lee, D. L. Pattarini, S. S. Walz, J. H. Tian, J. L. Pace, A. L. Bourgeois and R. I. Walker. 2005. Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccine. Vaccine 23, 4315-4321   DOI   ScienceOn
20 Felley, C. P., I. Corthesy-Theulaz, J. L. Rivero, P. Sipponen, M. Kaufmann, P. Bauerfeind, P. H. Wiesel, D. Brassart, A. Pfeifer, A. L. Blum and P. Michetti. 2001. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur. J. Gastrol. Hepatol. 13, 5-29   DOI
21 Yoon, Y. S., S. H. Lee, N. I. Baek, H. Y. Kim and C. H. Park. 2004. Inhibition of cell growth and urease activity of Helicobacter pylori by medicinal plant extracts. Kor. J. Biotechnol. 19, 187-191
22 Warren, J. R. and B. Marshall. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 11, 1273-1275
23 Ermak, T. H., P. J. Giannasca, R. Nichols, G. A. Myers, J. Nedrud, R. Weltzin, C. K. Lee, H. Kleanthous and T. P. Monath. 1998. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II - restricted responses. J. Exp. Med. 188, 2277-2288   DOI   ScienceOn
24 Nagy, B. 1980. Vaccination of cows with a K99 extract to protect newborn calves against experimental enterotoxic colibaillosis. Infect Immun. 21-24
25 Sutton, P. 2001. Theoretical article-Helicobacter pylori vaccines and mechanisms of effective immunity: Is mucus the key? Immunol. Cell Biolo. 79, 67-73   DOI   ScienceOn
26 Oscar, G. G., B. Lucas, Z. Yan, P. Klaus, H. Rainer and F. M. Thomas. 1998. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine 16, 460-471   DOI   ScienceOn
27 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 1994. Helicobacter pylori. in: Schistosomes, liver flukes, and Helicobacter pylori: views and expert opinions of IARC working group on the evaluation of carcirogenic risks to humans. Lyon: IARC Monogr Eval Carcinog Risks Hum. 61-241
28 Garvey, J. S., C. E. Natalie and H. S. Dieter. 1980. Methods in immunology, a laboratory text for instruction and research. W. A. Benjamin, Inc., Canada
29 Hogan, J. S., D. A. Todhunter, G. M. Tomita, K. L. Smith and P. S. Schoenberger. 1992. Opsonic activity of bovine serum and mammary secrection after Esherichia coli J5 vaccination. J. Dairy Sci. 75, 72-77   DOI   ScienceOn